Advertisement

Topics

Search Results for "Treatment Of Neurofibroma In India"

03:28 EDT 19th October 2017 | BioPortfolio

Matching Channels

India ink colloidal carbon stain

India

India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps ...

Pediculosis - louse (lice) treatment

   To view our most recent articles on Lice Treatment please go to: http://www.bioportfolio.com/news/article/987636/Pediculosis-Louse-Lice-Treatment.html    

Specific treatment

Hormonal treatment

Matching News

NeurofibromaPipeline Insights, 2017 [Updated: 30052017] Prices from USD $1063

DelveInsight's, NeurofibromaPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Neurofibroma. The DelveInsight'sReport covers...

UACT and others act to stop Xtandi patent in India

India’s Union for Affordable Cancer Treatment (UACT), along with 56 other organizations, has requested…

J&J, India's IMTECH collaborate on tuberculosis treatment R&D

Johnson & Johnson and India's Institute of Microbial Technology, part of the Council of Scientific and Industrial Research, w -More- 

Mylan HIV drug to be sold in India

Mylan's antiretroviral drug Avonza for first-line treatment of HIV/AIDS gained approval for release in India.  -More- 

Top 10 Pharmaceutical Companies in India By BizVibe

Over the last decade, pharmaceutical companies in India has witnessed tremendous growth and advances. With pharmaceutical research in India on the rise and advances in health, medical, and biotechnolo...

CORRECTING and REPLACING Top 10 Pharmaceutical Companies in India By BizVibe

Over the last decade, pharmaceutical companies in India has witnessed tremendous growth and advances. With pharmaceutical research in India on the rise and advances in health, medical, and biotechnolo...

Doctors in India meet to condemn practice of paying referral kickbacks to GPs

Doctors in India have publicly condemned the payment of commissions to fellow doctors who refer patients to them for diagnosis, treatment, or surgery, and are seeking government intervention to curb.....

Eisai introduces first─in─class epilepsy treatment Fycompa in India

Eisai Pharmaceuticals India Pvt. Ltd, a leading Japanese pharmaceutical company announced today the launch of Fycompa (perampanel), a new anti─epileptic drug. Approved in more than 55 countries worl...

Matching PubMed Articles

Differential Diagnosis Between Nasal Septal Schwannoma and Nasal Septal Neurofibroma.

Recently, as the authors experienced nasal septal schwannoma and nasal septal neurofibroma with similar clinical symptoms but different endoscopic findings, the authors tried to review all the literat...

Removal of solitary neurofibroma of the external nose by intranasal approach.

Solitary neurofibroma originating from the external nose is extremely rare, and to our knowledge, only 3 cases have been reported so far in English literatures. It may originate from the ophthalmic (V...

An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.

Neurofibromas are benign peripheral nerve tumors driven by NF1 loss in Schwann cells (SCs). Macrophages are abundant in neurofibromas, and macrophage targeted interventions may have therapeutic potent...

Successful treatment by negative-pressure wound therapy for ulcer located on diffuse plexiform neurofibroma.

Treatment options and barriers to case management of neonatal pneumonia in India: a protocol for a scoping review.

India contributes to the highest neonatal deaths globally. Case management is said to be the cornerstone of pneumonia control. Much of the published evidence focuses on children aged 1 to 59 months. T...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement